Association Between Stress Hyperglycemia Ratio and Cardiovascular Outcomes in Patients Who Underwent Complex
Jining He1,2,3, Zhangyu Lin1,2,3, Chenxi Song1,2,3
1Cardiometabolic Medicine Center, Fuwai Hospital, National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Insights
Elevated stress hyperglycemia ratio (SHR) predicts worse cardiovascular outcomes after complex percutaneous coronary intervention. This risk is particularly high for diabetic patients, aiding in risk stratification.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Complex percutaneous coronary intervention (PCI) carries a higher risk of adverse cardiovascular outcomes compared to non-complex procedures.
- Stress hyperglycemia ratio (SHR) is a biomarker for relative hyperglycemia, known to predict cardiovascular events in coronary artery disease patients.
- The prognostic value of SHR in patients undergoing complex PCI, a high-risk group, remained unclear.
Purpose of the Study:
- To investigate the association between SHR and long-term cardiovascular event risk in patients undergoing complex PCI.
- To determine if SHR can serve as a prognostic marker in this specific high-risk patient population.
Main Methods:
- A prospective cohort study included 12,220 patients undergoing complex PCI between January 2017 and December 2018.
- Patients were stratified into three baseline SHR tertiles (T1: ≤0.765, T2: 0.765-0.879, T3: >0.879).
- The primary endpoint comprised cardiovascular events, including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke, over a median 3-year follow-up.
Main Results:
- A total of 389 cardiovascular events were recorded among 10,772 patients who completed follow-up.
- Each one-unit increase in SHR was associated with a 1.62-fold increased risk of cardiovascular events after adjusting for confounders.
- Elevated SHR (T3 vs. T1) significantly increased cardiovascular event risk in diabetic patients (HR, 1.67) in fully adjusted models.
Conclusions:
- Elevated SHR levels are linked to increased long-term cardiovascular event risk in patients following complex PCI.
- SHR is a valuable tool for risk stratification and prognosis, especially in diabetic patients who underwent complex PCI.
- These findings highlight the importance of monitoring SHR in high-risk cardiovascular patients.
Background:
Complex percutaneous coronary intervention is associated with higher risk of long-term worse cardiovascular outcomes than noncomplex procedures. Stress hyperglycemia ratio (SHR), a biomarker to reflect relative hyperglycemia, has been shown to predict risk of cardiovascular events in patients with coronary artery disease. However, whether SHR-related cardiovascular risk could be seen in patients who underwent complex percutaneous coronary intervention who are at high risk of cardiovascular events remained undetermined.
Methods:
This prospective cohort study consecutively recruited 12 220 patients who underwent complex percutaneous coronary intervention from January 2017 to December 2018 at Fuwai Hospital. Patients were categorized according to baseline SHR tertiles (tertile 1: ≤ 0.765; T2: 0.765-0.879 and T3: > 0.879). The primary end point was cardiovascular events including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke.
Results:
During a median 3-year follow-up, 389 cardiovascular events (3.6% of the 10 772 patients who completed follow-up) were recorded. Overall, per 1-unit increase in SHR values was associated with 1.62-fold (95% CI, 1.10-2.38) risk of cardiovascular events after adjusting for confounding factors. Upon stratification by glycemic status, in the fully adjust model, elevated SHR was associated with increased risk of cardiovascular events in diabetic patients (T3 vs. T1; hazard ratio [HR], 1.67 [95% CI, 1.20-2.32]).
Conclusions:
We found that elevated SHR levels were associated with increased risk of cardiovascular events at long-term follow-up in patients who underwent complex percutaneous coronary intervention, especially in those with diabetes, suggesting that it could help in risk stratification and prognosis in this population.
Related Concept Videos
Hyperglycemia
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease I: Introduction
Hypoglycemia and Glucagon
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
